Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children

• Egile Nagusiak: Marcello Mariani (Egilea), Roberta Caorsi (Egilea), Alessandro Consolaro (Egilea), Giacomo Brisca (Egilea), Camilla Sticchi (Egilea), Marco Gattorno (Egilea), Elio Castagnola (Egilea), Angelo Ravelli (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract From March 2020 to July 2022, in Liguria region (North-West Italy) incidence of MIS-C among pediatric patients infected by SARS-CoV-2 was 38.7/100.000, which is higher than that of myocarditis after COVID-19 vaccination. In our opinion severity of MIS-C-related cardiac disease outweigh the...